In our March issue of Pharmaceutical Executive FEATURES
From the Editor Big Money and Big Data Lisa Henderson
No longer just hype, investing in big data is the path to the future for pharma, even if big returns aren't a direct result.
Cover Story Big Data: Is It Crunch Time for Pharma? Julian Upton
With big data one of the hot healthcare topics of the moment, we gauge pharma’s response to the hype to see if the industry is poised to take advantage of the promise of advanced analytics.
Technology Precision Medicine and Big Data Brandi Davis-Dusenbery
How integrating next-generation sequencing data can advance efforts in immuno-oncology research.
Technology Setting Sights on the Smart Supply Chain Julian Upton
Amid the push for a more intelligent and predictive supply chain, is it imperative for pharma companies to advance with their supply chain digitization strategies now—or is there still time to “wait and see?”
Biotech Roundtable The Quest for Translation Pharm Exec
Facing mixed market signals, biotech companies look to rise above the fray in advancing new-wave discoveries to the clinical finish line.